Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline

11Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.

Cite

CITATION STYLE

APA

Kooli, I., Brahim, H. B., Kilani, M., Gannouni, C., Aouam, A., Toumi, A., … Chakroun, M. (2016). Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline. Journal of Global Antimicrobial Resistance, 5, 62–63. https://doi.org/10.1016/j.jgar.2015.12.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free